This Morning With Gordon Deal This Morning with Gordon Deal December 25, 2025
Dec 25, 2025
Join Betsy McKay of The Wall Street Journal as she dives into groundbreaking cholesterol therapies beyond statins. Peter Evis from The New York Times breaks down recent tariff changes, revealing unexpected costs for shoppers. CNET's Patrick Holland shares eye-opening insights on iPhone battery performance and testing techniques. Finally, Aditi Shrikant shares the delicate balance between saving money staying with family during the holidays and the emotional toll it can take. Get ready for a mix of health, tech, and holiday wisdom!
AI Snips
Chapters
Transcript
Episode notes
Genetic Drugs Are Redefining Cholesterol Care
- New cholesterol drugs target genes like PCSK9 and can work differently than statins.
- Gene-editing therapies show large LDL and triglyceride drops but remain early and risky.
Lower LDL Targets Raise Treatment Needs
- Statins often aren't sufficient for high-risk patients and targets for LDL have dropped over time.
- Medical societies now recommend much lower LDL goals (around 55) for very high-risk people.
Confirm Who Pays Tariffs Before You Buy
- Exercise extreme caution buying from foreign sellers and confirm who will pay customs duties before checkout.
- Email the seller to get explicit confirmation that they will pay tariffs, or avoid the purchase.